NewsResearch
The multi-target stool DNA test reaches patients
A dated cancer milestone (2014): a noninvasive option in colorectal-cancer screening. Why it mattered, its limits, and how the field evolved.
Original commentary from the Cancer Explained editorial team.
Historical context: this page explains an event dated 2014. It was published as an explainer on July 12, 2026 and is not breaking news.
Please note: this page is educational only — it is not medical advice, and it does not speculate about anyone’s health beyond reliable public reporting. For questions about your own health, talk with your healthcare team.
Historical milestone — this page describes an event dated 2014. It is not current breaking news.
In brief
The multi-target stool DNA test reaches patients (2014). A noninvasive option in colorectal-cancer screening.
What happened
The multi-target stool DNA test reaches patients, dated to 2014. A noninvasive option in colorectal-cancer screening. Specific dates and attributions are held for verification against historical sources.
Why it changed cancer care or understanding
A noninvasive option in colorectal-cancer screening. Milestones like this help explain how today's cancer care and understanding came to be.
The context of the time
Set against the knowledge and tools of its time, this step marked a meaningful change in direction.
What this story cannot tell you
- A historical milestone reflects the knowledge and standards of its era, not today's.
- Early breakthroughs were often limited, and the field kept evolving afterward.
How the field evolved afterward
Later research built on, refined, and in some cases corrected this development.
Present-day relevance
Colorectal cancer begins in the colon or rectum, the lower part of the digestive system. Most cases develop over years from growths called polyps. Major U.S. guidelines recommend regular screening for people at average risk beginning at age 45, using a stool-based test or a visual exam such as colonoscopy. The right test and timing are individual decisions.
Sources
This article was written from the sources below, which were checked on the source-check date shown above.
- AAFP: Multitarget stool DNA testing (Cologuard) (secondary)
How this article was prepared
Prepared by Cancer Explained's AI-assisted editorial system and checked against the sources listed below. This article has not been reviewed by a healthcare professional unless a named reviewer is specifically shown.
Cancer Explained is published by the National Cancer Information Foundation as a nonprofit-oriented public-interest education project. It is not a diagnostic service, does not recommend treatments, and is not for emergencies.
Found an error, a broken source link, outdated information, or wording that feels insensitive? Report it here — we log and act on material corrections.